Nagai K - Search Results

1

Weight Loss Improves Liver Dysfunction and Dipstick Proteinuria in Obesity: The Japan Specific Health Checkups Study.

Nagai K, Harada T, Mase K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T, Yamagata K. Nagai K, et al. JMA J. 2023 Jul 14;6(3):312-320. doi: 10.31662/jmaj.2023-0008. Epub 2023 Jun 30. JMA J. 2023. PMID: 37560360 Free PMC article.

2

Annual incidence of persistent proteinuria in the general population from Ibaraki annual urinalysis study.

Nagai K, Saito C, Watanabe F, Ohkubo R, Sato C, Kawamura T, Uchida K, Hiwatashi A, Kai H, Ishida K, Sairenchi T, Yamagata K. Nagai K, et al. Clin Exp Nephrol. 2013 Apr;17(2):255-60. doi: 10.1007/s10157-012-0692-5. Epub 2012 Sep 13. Clin Exp Nephrol. 2013. PMID: 22971964

3

Birth weight and end-stage diabetic nephropathy in later life: a Japanese multicenter study.

Nagai K, Saito C, Yamagata K. Nagai K, et al. Ther Apher Dial. 2014 Feb;18(1):111-2. doi: 10.1111/1744-9987.12159. Epub 2014 Jan 13. Ther Apher Dial. 2014. PMID: 24417884 No abstract available.

4

Successful use of tocilizumab in a case of multicentric Castleman's disease and end-stage renal disease.

Nagai K, Ueda A, Yamagata K. Nagai K, et al. Ther Apher Dial. 2014 Apr;18(2):210-1. doi: 10.1111/1744-9987.12128. Epub 2013 Oct 31. Ther Apher Dial. 2014. PMID: 24571441 No abstract available.

5

Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria.

Nagai K, Yamagata K, Ohkubo R, Saito C, Asahi K, Iseki K, Kimura K, Moriyama T, Narita I, Fujimoto S, Tsuruya K, Konta T, Kondo M, Watanabe T. Nagai K, et al. Nephrology (Carlton). 2014 Sep;19(9):574-80. doi: 10.1111/nep.12286. Nephrology (Carlton). 2014. PMID: 24899111

6

Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method.

Nagai K, Yamagata K. Nagai K, et al. Clin Exp Nephrol. 2015 Feb;19(1):152-3. doi: 10.1007/s10157-014-1034-6. Epub 2014 Sep 24. Clin Exp Nephrol. 2015. PMID: 25248505 No abstract available.

7

Annual decline in pentraxin 3 is a risk of vascular access troubles in hemodialysis patients.

Nagai K, Ueda A, Saito C, Zempo-Miyaki A, Yamagata K. Nagai K, et al. Int J Nephrol. 2014;2014:297954. doi: 10.1155/2014/297954. Epub 2014 Dec 22. Int J Nephrol. 2014. PMID: 25587447 Free PMC article.

8

Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up.

Nagai K, Sairenchi T, Irie F, Watanabe H, Ota H, Yamagata K. Nagai K, et al. PLoS One. 2016 Jun 6;11(6):e0156792. doi: 10.1371/journal.pone.0156792. eCollection 2016. PLoS One. 2016. PMID: 27272675 Free PMC article.

9

Use of darbepoetin alfa for myelodysplastic syndrome coincident with chronic kidney disease.

Nagai K, Yamagata K. Nagai K, et al. CEN Case Rep. 2016 May;5(1):117-118. doi: 10.1007/s13730-016-0212-7. Epub 2016 Jan 22. CEN Case Rep. 2016. PMID: 28509181 Free PMC article. No abstract available.

10

A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study.

Hoshino J, Nagai K, Kai H, Saito C, Ito Y, Asahi K, Kondo M, Iseki K, Iseki C, Okada H, Kashihara N, Narita I, Wada T, Combe C, Pisoni RL, Robinson BM, Yamagata K. Hoshino J, et al. Among authors: nagai k. Clin Exp Nephrol. 2018 Apr;22(2):309-317. doi: 10.1007/s10157-017-1453-2. Epub 2017 Jul 24. Clin Exp Nephrol. 2018. PMID: 28741051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,897 results

Search Page

Filters